Ascendis Pharma A (ASND) Net Equity Issued and Repurchased (2013 - 2024)

Ascendis Pharma A (ASND) posted Net Equity Issued and Repurchased of $20.6 million for Q4 2024, up 9285.38% sequentially from $219642.4 in Q4 2021.

Analysis

Ascendis Pharma A (ASND) Net Equity Issued and Repurchased (2013 - 2024) Analysis & Trends

Ascendis Pharma A has reported Net Equity Issued and Repurchased for 2 years, with the latest figure at $20.6 million in Q4 2024.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	49.20 Mn
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	-
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	-
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	141.90 Mn
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	-
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	-
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	-
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	-
10	Ascendis Pharma A	16.39 Bn	15.45 Bn	362.22 Mn	-

Historic Data

Download Data